Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This issue peaked at week 24 and then declined at weeks 36 and 48
$1.8B Samsung Biologics PolyPeptide Acquisition Targets GLP-1 Obesity Drug Market South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has initiated an all-cash public tender offer to acquire 100% of Switzerland-based PolyPeptide Group AG
Skin lightening treatment is designed to decrease excessive melanin in the skin
Our GLP-1 with Synbiotic blend (prebiotics + probiotics) helps maintain good gut bacteria for digestive balance and comfort
The condition is reversible upon discontinuation of IGF-1 LR3
Sobo approaches medical weight loss as long-term metabolic care
US$ 24.50
US$ 21.42
US$ 27.72
US$ 28.88
US$ 26.09
US$ 20.85
US$ 24.61
US$ 28.63
